{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:03:48Z","timestamp":1762607028145,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.msard.2017.07.010","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T04:46:59Z","timestamp":1499921219000},"page":"144-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Tackling comorbidity in multiple sclerosis"],"prefix":"10.1016","volume":"17","author":[{"given":"Gisela","family":"Kobelt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1097","key":"10.1016\/j.msard.2017.07.010_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/postgradmedj-2016-134071","article-title":"Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life","volume":"93","author":"Campbell","year":"2017","journal-title":"Postgrad. Med. J."},{"issue":"9936","key":"10.1016\/j.msard.2017.07.010_bib2","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(13)62242-4","article-title":"Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial","volume":"383","author":"Chataway","year":"2014","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.msard.2017.07.010_bib3","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1001\/archinternmed.2010.301","article-title":"Quality of life and cost-effectiveness of a 3-year trial of lifestyle intervention in primary health care","volume":"170","author":"Eriksson","year":"2010","journal-title":"Arch. Int. Med."},{"issue":"Suppl 1","key":"10.1016\/j.msard.2017.07.010_bib4","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: time matters in multiple sclerosis","volume":"9","author":"Giovannoni","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2017.07.010_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/1352458517694432","article-title":"New insights into the burden and costs of multiple sclerosis in Europe","author":"Kobelt","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2017.07.010_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2017.33","article-title":"Comorbidity in multiple sclerosis: implications for patient care","author":"Marrie","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2017.07.010_bib7","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3899\/jrheum.141112","article-title":"Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: expert opinion of the canadian dermatology-rheumatology comorbidity initiative","volume":"42","author":"Roubille","year":"2015","journal-title":"J. Rheumatol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103481730158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103481730158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:40:29Z","timestamp":1761900029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103481730158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":7,"alternative-id":["S221103481730158X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2017.07.010","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tackling comorbidity in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2017.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}